International Journal of Pharmaceutical and Phytopharmacological Research
ISSN (Print): 2250-1029
ISSN (Online): 2249-6084
Publish with eIJPPR Submission
2026   Volume 16   Issue 3

Federated Learning for Cross-Institutional Phytochemical Discovery: Collaborative Model Development Without Centralized Sensitive Data Sharing
Download PDF


, ,
  1. Department of AI for Adaptogenic and Nootropic Plant Extracts, Faculty of Pharmacy, Semmelweis University, Budapest, Hungary.
  2. Department of Machine Learning for Cognitive Enhancement Targets, Faculty of Pharmacy, University of Pécs, Pécs, Hungary.
Citation
Vancouver
Kovács Z, Szabo K, Nagy G. Federated Learning for Cross-Institutional Phytochemical Discovery: Collaborative Model Development Without Centralized Sensitive Data Sharing. Int J Pharm Phytopharmacol Res. 2026;16(3):100-16. https://doi.org/10.51847/y0yuNXQ0Gg
APA
Kovács, Z., Szabo, K., & Nagy, G. (2026). Federated Learning for Cross-Institutional Phytochemical Discovery: Collaborative Model Development Without Centralized Sensitive Data Sharing. International Journal of Pharmaceutical And Phytopharmacological Research, 16(3), 100-116. https://doi.org/10.51847/y0yuNXQ0Gg
Download citation:   EndNote   RIS
Article Link:
Downloads: 32
Views: 114
Abstract

Cross-institutional phytochemical discovery increasingly depends on distributed chemical, biological, omics, safety, provenance, and proprietary datasets that cannot always be transferred to a central repository. Although federated learning may enable participating institutions to develop shared computational models while retaining source data locally, data locality alone does not resolve privacy leakage, cybersecurity, data heterogeneity, scientific validity, governance, or institutional-trust concerns. This article proposes a conceptual federated learning architecture for collaborative phytochemical discovery across natural product laboratories, academic institutions, pharmaceutical research groups, bioinformatics centers, and other authorized partners. The architecture links consortium formation and data-governance agreements with local data stewardship, metadata harmonization, feature and label alignment, local model training, governed model-update exchange, global aggregation, privacy and security safeguards, cross-site validation, bias assessment, expert review, model documentation, lifecycle governance, and structured feedback. It accommodates phytochemical records, chemical representations, bioactivity and assay data, target and pathway annotations, omics evidence where supported, ADMET and toxicity information, proprietary compound libraries, and carefully governed traditional knowledge, biodiversity, clinical, or pharmacovigilance signals where appropriate. The principal contribution is an architecture that treats federated learning as one component of a broader scientific and governance system rather than as an automatic privacy or discovery solution. The proposed framework supports research collaboration and hypothesis prioritization but does not establish privacy certification, security certification, therapeutic validity, clinical utility, regulatory readiness, or operational deployment.

Related articles:
Most viewed articles:
Naproxen in Pain and Inflammation – A Review
Vol 11 Issue 1, 2021 | Svetoslav Nikolaev Stoev
An Overview on Emulgel
Vol 9 Issue 1, 2019 | Sreevidya V.S
Volume 16
Issue 4
2026

Call for Papers
[email protected]
Issues
Associations
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright © 2026 International Journal of Pharmaceutical and Phytopharmacological Research
Authors retain copyright of their article if they are accepted for publication.